Combining Radiotherapy and Immunotherapy in Definitive Treatment of Head and Neck Squamous Cell Carcinoma: Review of Current Clinical Trials

BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) presents as locally advanced disease in a majority of patients and is prone to relapse despite aggressive treatment. Since immune checkpoint inhibitors (ICI) have shown clinically significant efficacy in patients with recurrent/metastatic HNS...

Descripción completa

Detalles Bibliográficos
Autores principales: Plavc, Gaber, Strojan, Primoz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585335/
https://www.ncbi.nlm.nih.gov/pubmed/33064670
http://dx.doi.org/10.2478/raon-2020-0060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585335/
https://www.ncbi.nlm.nih.gov/pubmed/33064670
http://dx.doi.org/10.2478/raon-2020-0060

Ejemplares similares